3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
6
Lung Neoplasms
4
Prostatic Neoplasms
2
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Rectal Neoplasms
1
Pancreatitis, Chronic
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neurocognitive Disorders
1
Melanoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Immunoglobulin G4-Related Disease
1
Carcinoma, Renal Cell
1
Breast Neoplasms
1
Breast Carcinoma In Situ
1
Autoimmune Pancreatitis
1
Anus Neoplasms
1
Anatomic Stage II Breast Cancer AJCC v8
1
Anal Canal Carcinoma
1
Interventions
Cisplatin
4
Cetuximab
3
pembrolizumab
2
Surveys and Questionnaires
2
Radiotherapy
2
Carboplatin
2
olaparib
1
niraparib
1
fludarabine
1
dostarlimab
1
calcipotriene
1
avelumab
1
atezolizumab
1
aldesleukin
1
Watchful Waiting
1
Tiragolumab
1
Standard of Care
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Platinum
1
Phlebotomy
1
Paclitaxel
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Fluorouracil
1
Fluorodeoxyglucose F18
1
Docetaxel
1
Cyclophosphamide
1
Bronchoscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Squamous Cell
×
Observation
×
30 days
×
Clear all
No trials found.